Monoclonal Antibodies and Breast Cancer: Proceedings of the International Workshop on Monoclonal Antibodies and Breast Cancer San Francisco, Californi (Hardcover, 1985)

Session I.- 1. Immunostaining of Estrogen Receptors in Paraffin Sections of Breast Cancers Using Anti-Estrophilin Monoclonal Antibodies.- 2. Clinical Studies on Cell Surface Estrogen-Regulated Proteins.- 3. MAM-6, a Carcinoma Associated Marker: Preliminary Characterisation and Detection in Sera of Breast Cancer Patients.- 4. Monoclonal Antibodies in the Study of Mammary Development and Neoplasia.- 5. Monoclonal Antibodies in the Study of Cell Lineage, Differentiation and Malignancy in the Human Breast.- 6. Studies with Monoclonal Antibodies to Breast Tumors.- Session II.- 7. Serological Dissection of Human Breast Cancer with Mouse and Human Monoclonal Antibodies.- 8. Potential Clinical Application of a Monoclonal Antibody to a Tumor Associated Glycoprotein (TAG-72).- 9. Immunocytochemistry for the Selection of Hybridomas and the Characterization of Monoclonal Antibodies: Problems, Solutions and Suggestions.- 10. Effector Cells in ADCC with Anti-Breast Cancer Monoclonal Antibodies.- Session III.- 11. Use of Monoclonal Antibodies for Breast Cancer Diagnosis and Prognosis.- 12. Intracellular and Extracellular Keratins of Human Mammary Epithelial Cells.- 13. Breast Cancer Antigens Detected with Human Monoclonal Antibodies.- 14. Monoclonal Antibodies Against Estrogen Receptor: Specificity, Sensitivity and Potential Applications.- Session IV.- 15. Monoclonal Antibodies in the Characterization and Imaging of Human Breast Cancers.- 16. Use of Monoclonal Antibodies to Detect Metastases of Solid Tumors in Lymph Nodes.- 17. Detection of Breast Cancer Using the Monoclonal Antibody 3E-1.2.- 18. An Experimental Model for the Immunological Treatment of Breast Cancer.- 19. Breast Cancer Immunotoxins.- 20. Ductal Carcinoma Antigen: Characteristics, Tissue Distribution and Capacity to Represent a Target for Monoclonal Antibody Therapy.- 21. Non-Immunological Factors Affecting the Localization of Monoclonal Antibodies in Xenografts of Human Breast and Colon Tumors.